Healthconn Corp. (6665) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Healthconn Corp. TWD 13.18, price TWD 17.30, upside -23.8%, quality 54 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Healthconn Corp. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 16.70 TWD – 52.90 TWD · the 17.30 TWD price screens above the 13.18 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Healthconn in your weekly email
Every Wednesday you see whether Healthconn is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Healthconn Corp. engages in the health services management in Taiwan and China. The company engages in the provision of health promotion consulting services, precision medicine health management services; genetic testing; and sales of molecular biology, genetics, microbial life science testing, precision instruments, and reagents.
Show more
Healthconn Corp. engages in the health services management in Taiwan and China. The company engages in the provision of health promotion consulting services, precision medicine health management services; genetic testing; and sales of molecular biology, genetics, microbial life science testing, precision instruments, and reagents. It also offers diagnostic solutions, including microbiology, total lab automation, molecular biology, life sciences, laboratory information systems, and environment and safety solutions; and warehouse and logistics solutions. Healthconn Corp. was founded in 2009 and is based in Taipei, Taiwan.
Stock analysis
Healthconn Corp. (6665) currently trades at 17.30 TWD, while our model-based Fair Value estimate is 13.18 TWD, implying the stock looks roughly 31.3% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 17.00 TWD per share, and 6 of the 26 models we run sit above the 17.30 TWD price.
Bear case: the Earnings-Based group reads lowest at 1.71 TWD, and 20 of the 26 models stay below the price. Evidence for this calculation is low.
Quality & growth
The Quality Score stands at 54/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Healthconn Corp. reported revenue of 1.1B TWD in FY2025 versus 1.4B TWD in FY2021, a compound −4.6%/yr. Reported net income was 8.4M TWD in FY2025, compounding −31.2%/yr from FY2021.
Key figures
Market cap 882M TWD (≈ $27.7M) · P/E ratio 91.1 · P/S ratio 0.68 · EPS (TTM) 0.1900 TWD · Dividend yield 0.9% · Net margin 0.7% · Return on equity 0.9% · Return on assets (EBIT) 1.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 28% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 21% fair-value upside, at −24%, 6665 screens richer than that median.
Fair Value models
Bear 13.18 TWDFair Value 13.18 TWDBull 13.18 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.0308 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−9.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+30.1%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.5%
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−40.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−41.0%
Dividend (yield on the price)0.9%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−41% vs −25%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.10% → 0%
Start year 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−22.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about −23.4% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Healthcare Plans · 15 stocks
Beats the industry median on 2/13 measures
Overall it trails its industry peers.
Valuation
Quality Score54 · Below median
Fair Value upside−22% · Bottom 25%
Profitability
Return on equity (TTM)1% · Bottom 25%
Return on assets0% · Bottom 25%
Net margin (TTM)1% · Below median
Operating margin (TTM)1% · Bottom 25%
Growth and dividend
Revenue growth−11% · Bottom 25%
Dividend yield (TTM)0.9% · Bottom 25%
Valuation Multiplesvs Healthcare Plans median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Healthconn Corp. Fair Value". https://www.fairvalue-calculator.com/stock/6665
Frequently asked questions
Is Healthconn Corp. (6665) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 13.18 TWD versus a price of 17.30 TWD, about −24% upside (overvalued).
What is the fair value of 6665?
Our model-based fair value for Healthconn Corp. is 13.18 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 17.30 TWD.
What is the quality score of 6665?
Healthconn Corp. has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Healthconn Corp. (6665)?
Our model-based price target is the fair value of 13.18 TWD (as of Sep 24, 2026) from 26 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Healthconn Corp. stock forecast for 2026?
Our models put fair value at 13.18 TWD, about −24% upside versus a price of 17.30 TWD (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Healthconn Corp. (6665)?
Healthconn Corp. reported trailing-twelve-month revenue of about 1.1B TWD (latest available figure, as of Sep 24, 2026).
Does Healthconn Corp. pay a dividend?
Healthconn Corp. currently shows a dividend yield of about 0.86% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Healthconn Corp. (6665)?
For today's price to be fair in a discounted-cash-flow model, Healthconn Corp. would have to grow free cash flow by -22.2 % per year for five years (discount rate 9.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +30.1 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 6665 use?
Our models discount Healthconn Corp. at 9.0 %: a base by market capitalisation (nano), damped by beta 0.40, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Healthconn Corp. that is -22.2 % per year a year over ten years, using the same discount rate (9.0 %) and the same formula as our fair value.
How much growth has Healthconn Corp. (6665) delivered so far?
Over the past 5 years revenue at Healthconn Corp. grew +30.1 % a year. The price currently implies -22.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Healthconn Corp. (6665) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Healthconn Corp. (-22.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Healthconn Corp. (6665)?
The free-cash-flow yield on the price is 5.49 %: that much free cash flow Healthconn Corp. produces per unit of market value. When it exceeds the discount rate of our models (9.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Healthconn Corp. (6665)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Healthconn Corp. it is 13.18 TWD per share (as of Sep 24, 2026), against a price of 17.30 TWD. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Healthconn Corp. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 6665 trades above its calculated fair value: price 17.30 TWD, fair value 13.18 TWD, a gap of about −24% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6665?
No. The price is what the market pays today (17.30 TWD); the fair value is what the company's own numbers justify (13.18 TWD). For Healthconn Corp. the two are 4.12 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Healthconn Corp. worth?
The market values Healthconn Corp. at about 882M TWD (market capitalisation, as of Sep 24, 2026). Per share that is 17.30 TWD; our models calculate a fair value of 13.18 TWD per share.
What is the P/E ratio of 6665?
Healthconn Corp. trades at a price-to-earnings ratio of 91.1 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 13.18 TWD is built from several models across several years. Other multiples: P/B 1.0, P/S 0.8, EV/EBITDA 21.7.
How solid is the balance sheet of Healthconn Corp. (6665)?
Balance-sheet figures for Healthconn Corp. (as of Sep 24, 2026): return on equity 0.9%. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is 6665 from its 52-week high?
Healthconn Corp. trades at 17.30 TWD, about 28% below its 52-week high of 23.98 TWD and 4% above the low of 16.70 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 13.18 TWD is for.
Which stocks are comparable to Healthconn Corp.?
From the same area (Healthcare) we also value UnitedHealth Group, CVS Health Corporation, Elevance Health, Inc, The Cigna Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Healthconn Corp. stock attractive at the current price?
The data as of Sep 24, 2026: price 17.30 TWD, calculated fair value 13.18 TWD (−24%), Quality Score 54/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6665 calculated?
We run Healthconn Corp. through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 13.18 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Healthconn Corp. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Healthconn Corp. (6665)?
The closing price on Sep 24, 2026 was 17.30 TWD. Our model-based fair value is 13.18 TWD, about −24% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Healthconn Corp. right now?
The price sits above even our optimistic bull case (13.18 TWD). The favourable scenario is already priced in. Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Healthconn Corp.
How large is the market capitalisation of Healthconn Corp. (6665)?
The market capitalisation of Healthconn Corp. is 882M TWD (≈ $27.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Healthconn Corp. (6665)?
The price-to-sales ratio of Healthconn Corp. is 0.68 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Healthconn Corp. (6665)?
Earnings per share at Healthconn Corp. are 0.1900 TWD (price ÷ EPS = P/E 91.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Healthconn Corp. (6665)?
The dividend yield of Healthconn Corp. is 0.9% (payout 77.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Healthconn Corp. (6665)?
The net margin of Healthconn Corp. is 0.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Healthconn Corp. (6665)?
The return on equity (ROE) of Healthconn Corp. is 0.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Healthconn Corp. (6665)?
On an EBIT basis the return on assets of Healthconn Corp. is 1.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Healthconn Corp. (6665)?
The operating margin of Healthconn Corp. is 1.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Healthconn Corp. (6665)?
Revenue at Healthconn Corp. is growing −11.1% versus a year earlier (3y avg −9.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Healthconn Corp. (6665)?
Earnings per share at Healthconn Corp. are growing −37.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Healthconn Corp. (6665) hold?
Healthconn Corp. holds more cash than debt, 285M TWD net (fiscal year 2023). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Healthconn Corp. in the live analysis
One click puts Healthconn Corp. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
